Importance of marrow dose on posttransplant outcome in acute leukemia
- 1 December 1999
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 27 (12) , 1822-1830
- https://doi.org/10.1016/s0301-472x(99)00121-6
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Preliminary Results of Treatment with Filgrastim for Relapse of Leukemia and Myelodysplasia after Allogeneic Bone Marrow TransplantationNew England Journal of Medicine, 1993
- Autologous Bone Marrow Transplantation in Childhood Acute Lymphoid Leukemia with Use of PurgingJournal of Pediatric Hematology/Oncology, 1993
- Bone Marrow Purging for Autologous Bone Marrow TransplantationLeukemia & Lymphoma, 1993
- The Role of Autologous Bone Marrow Transplantation in Acute LeukemiaAnnals of the New York Academy of Sciences, 1987
- Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-HydroperoxycyclophosphamideNew England Journal of Medicine, 1986
- Collection, manipulation and freezing of haemopoietic stem cellsClinics in Haematology, 1986
- AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN RELAPSED ADULT ACUTE LEUKÆMIAThe Lancet, 1979
- AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ACUTE MYELOCYTIC LEUKÆMIAThe Lancet, 1977
- Human bone marrow colony growth in agar‐gelJournal of Cellular Physiology, 1970
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958